Novel therapeutic approaches for COVID-19 in chronic kidney disease and transplant.

Document Type

Article

Publication Date

1-2021

Publication Title

Current Opinion in Nephrology and Hypertension

Abstract

PURPOSE OF REVIEW: Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is the novel virus responsible for the current worldwide pandemic. The scientific and healthcare communities have made every effort to discover and implement treatment options at a historic pace. Patients with kidney disease are uniquely vulnerable to an infectious pandemic because of their need to be in frequent contact with the healthcare system for life-sustaining renal replacement therapy whether it be by dialysis or transplant.

RECENT FINDINGS: The use of targeted viral therapies, extracorporeal therapies, immunosuppressive therapy and public health interventions are important in the management of patients with COVID-19 but require special consideration in patients with kidney disease because of the complexity of their condition.

SUMMARY: Here, we discuss some of the major efforts made to prevent spread and emerging treatment options for this virus, as they pertain to patients with kidney disease.

Volume

30

Issue

1

First Page

47

Last Page

53

DOI

10.1097/MNH.0000000000000671

ISSN

1473-6543

PubMed ID

33186223

Link to Full Text

Share

COinS